"The main idea in golf as in life, I suppose, is to learn to accept what cannot be altered and to keep on doing one's own reasoned and resolute best whether the prospect be bleak or rosy".

                                                                                       -- Bobby Jones

Amos E. Wasgatt, III lost his courageous battle against a malignant brain tumor on December 13, 2005. Throughout his fight, he was determined to play as many rounds of golf as possible. With each surgery and treatment, he always asked: "How soon until I can get out and play 18?" The amazing care and radical treatments Dana-Farber made available allowed Amos to continue enjoying one of his great passions in life - the game of Golf.

The Amos E. Wasgatt, III Memorial Golf Tournament will support the cutting-edge work being done at the Center for Neuro-Oncology at Dana-Farber Cancer Institute. The Brain Tumor Research Fund supports the research and programs provided at the Center for Neuro-Oncology, whose mission is to provide expert care and the best possible treatment for patients with brain cancer.

Through the conduct of clinical and basic research, the Center for Neuro-Oncoloty's goal is to discover new and effective therapies for the treatment of patients with brain tumors. The program also aims to develop innovative combination strategies to enhance the therapeutic effects of chemotherapy and radiation treatments. Another important goal of the program is to develop and fund translational research opportunities to bring new agents and strategies rapidly from the laboratory to the clinical setting.

We hope you join us for a day of golf in memory of Amos E. Wasgatt, III. You are helping us provide hope to those affected by brain tumors.

Each year in the United States, approximately 40,000 peolpe will be diagnosed with primary brain tumors, of which nearly 20,000 are malignant. In addition, over 170,000 people each year will be diagnosed with metastatic brain tumors (tumors that have spread to the brain from a caner elsewhere in the body). Despite advances in treatment, the outcome is still poor and we desperately need better therapies.